Results 151 to 160 of about 106,373 (291)

Application of nitroxoline in urologic oncology – a review of evidence

The persistence of high incidence and mortality rates associated with urologic cancers underscores the urgent need for effective and safe treatments.
Bartosz Małkiewicz, Łukasz Nowak, Wojciech Krajewski, Tomasz Szydełko, Katarzyna Grunwald, Jan Łaszkiewicz, Joanna Chorbińska, Wojciech Tomczak, Adam Chełmoński, Szymon Pisarski   +9 more
core   +1 more source

Cancer co‐medication quality in older patients with polypharmacy: A large randomized trial testing a medication review versus usual care

Journal of Internal Medicine, EarlyView.
Abstract Background Evidence from randomized controlled trials (RCTs) testing medication reviews in geriatric oncology is sparse. Methods We conducted a single‐blinded RCT in ten rehabilitation clinics across Germany. Patients with common cancers, aged ≥ 65 years, and polypharmacy (regularly ≥ five drugs) were randomly allocated in equal proportions to
Miriam Degen, Annette Kopp‐Schneider, Tomislav Vlaski, Sigrid Carlsson, Peter Hallermann, Ludmilla Jewlanowa, Jana Barinoff, Valentin Goede, Christian Lüders, Thomas Kiefer‐Trendelenburg, Diana Lüftner, Jasmin Doll, Jürgen Wagner, Birgit Leibbrand, Hermann Brenner, Ben Schöttker   +15 more
wiley   +1 more source

Evaluation of Mutation Risk Using Patient‐Derived Organoids in Patients With Lynch Syndrome

International Journal of Cancer, Volume 159, Issue 10, Page 2585-2594, 15 November 2026.
ABSTRACT Lynch syndrome (LS) is a hereditary cancer predisposition syndrome caused by germline mutation of DNA mismatch repair (MMR) genes, most notably associated with colorectal cancer. Although LS patients face high risk of CRC, risk can vary even among those with the same pathogenic MMR germline mutations. We suggest a functional assay platform for
Youmi Shin, Dong Keon Kim, Yoojeong Seo, Hyeon Hee Lee, Jihye Park, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Jongwon Oh, Sanghoo Lee, Tae Il Kim   +10 more
wiley   +1 more source

Association Between Menopausal Hormone Therapy and the Risk of Urologic Cancer: A National Population-Based Retrospective Cohort Study in Korea. [PDF]

J Korean Med Sci
Yuk JS, Yoon SH, Cho DY, Oh N, Kim JY.
europepmc   +1 more source

Male urologic cancers [PDF]

During 2013\u20132017, one of three cancers diagnosed in men was a urologic cancer. Of 302,304 urologic cancers diagnosed each year, 67% were found in the prostate, 19% in the urinary bladder, 13% in the kidney or renal pelvis, and 3% in the testis ...

core  

High‐Throughput Geocoding to Assess Short‐Term Air Pollution in Correlation With Mortality in a French Cancer Patient Cohort

International Journal of Cancer, Volume 159, Issue 8, Page 2054-2065, 15 October 2026.
Although chronic air pollution exposure is linked to lung cancer mortality, the short‐term effects of fluctuating air quality on overall cancer mortality remain uncertain. Here, the authors applied geomatics and machine‐learning models to retrospectively examine possible associations between 31‐day pollution exposure and mortality in a French cancer ...
Loice Pokam, Joséphine Bocquet, Nadia Hégarat, Julie Perlbarg‐Samson, Thomas Balezeau, Maud Milder, Bastien Rance, Hector Countouris, Julien Guerin, Flavien Gilles, Jean Gaudart, Nicolas Girard, Clémence Basse   +12 more
wiley   +1 more source

Urologic malignancy in renal transplant recipients: Analysis of OPTN/UNOS data from 2000 to 2022. [PDF]

BMC Cancer
Hao X, Ye C, Lai W, Xu J, Wu Y, Sun Y, Pang H, Lv C, Lv K, Yang G, Wang J, Gao Y, Lu Y, Huang S, Luo Z, Dong J, Zhao M, Zhang X, Chen H, Yuan Q.   +19 more
europepmc   +1 more source

Refining risk stratification after indeterminate urinary cytology: Evidence from Bladder EpiCheck

Cancer Cytopathology, Volume 134, Issue 10, October 2026.
Abstract Background This study aimed to evaluate Bladder EpiCheck (BE) performance in detecting urothelial carcinoma (UC) and HG (high‐grade) events in patients with indeterminate cytology and negative cystoscopy. Methods This prospective study included 63 patients who presented with indeterminate urinary cytology and negative cystoscopy between ...
Claudia Mercader, Mercedes Ingelmo‐Torres, Fiorella L. Roldán, Marcel Figueras, Eric Villalba, Pilar Galve, Ignacio Asiaín, Meritxell Costa, Antoni Vilaseca, Josep Oriola, Agustín Franco, Antonio Alcaraz, Lourdes Mengual   +12 more
wiley   +1 more source

Treatment-related Risk of Urologic Adverse Events in Cervical Cancer Survivors. [PDF]

Urology
Powell J, Myers JB, Horns JJ, Woodle T, Dood R, Kurtzman JT.   +5 more
europepmc   +1 more source

Multiple neoplasms, single primaries, and patient survival

, 2014
Magid H Amer Department of Medicine, St Rita's Medical Center, Lima, OH, USA Background: Multiple primary neoplasms in surviving cancer patients are relatively common, with an increasing incidence.
Amer MH
core